Question

A $58$-year-old man is evaluated in the emergency department for severe, acute-onset pain, swelling, and redness of his right knee. He is a renal transplant recipient and his current immunosuppressive regimen includes azathioprine, tacrolimus, and low-dose prednisone. He also has a history of peptic ulcer disease with a recent gastrointestinal hemorrhage. His temperature is $37.8^\circ\text{C}$ ($100.0^\circ\text{F}$). Serum laboratory studies show a creatinine level of $2.9\text{ mg/dL}$ and a uric acid level of $5.8\text{ mg/dL}$ (normal: $4.0-8.5\text{ mg/dL}$). Joint aspiration yields cloudy synovial fluid with a leukocyte count of $55,000/\mu\text{L}$ ($85\%$ neutrophils) and negatively birefringent, needle-shaped crystals. Due to the patient's medical history, several standard therapies are deemed high-risk. The physician decides to administer a targeted biologic agent appropriate for the acute management of this condition. Inhibition or neutralization of which of the following is the primary mechanism of action of the most appropriate therapy for this patient's current symptoms?